Carla J Greenbaum

Trials

Studies that name Carla J Greenbaum as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT01773707 · CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1

  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Abnormal Glucose Tolerance, Type 1 Diabetes · study chair
• Ph2
  NCT01030861 · Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"

  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk · study chair
• Ph3
  NCT00419562 · Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Diabetes Mellitus, Type 1 · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Type 1 Diabetes TrialNet Clinical Network Hub
  U01DK103282 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · fiscal years 2014 to 2026 · $1,000,000 awarded in 2026
  Same name and institution; not confirmed by an ID
• Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D
  U01DK127404 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · fiscal years 2020 to 2024 · $215,625 awarded in 2024
  Same name and institution; not confirmed by an ID
• Northwest Clinical Center for Type 1 Diabetes - TrialNet
  U01DK061034 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · fiscal years 2001 to 2018 · $635,581 awarded in 2018
  Same name and institution; not confirmed by an ID
• In Vivo Assessment of T Cell Kinetics in Individuals at Risk for Type 1 Diabetes
  DP3DK098217 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · fiscal years 2013 · $1,134,652 awarded in 2013
  Same name and institution; not confirmed by an ID
• AIRmax as sensitive measure of beta cell function in at-risk individuals
  DP3DK096744 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · fiscal years 2012 · $1,060,000 awarded in 2012
  Same name and institution; not confirmed by an ID
• DQB1*0602 RELATIVES--MECHANISMS FOR DIABETES PROTECTION
  R01AI044431 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · fiscal years 1999 to 2001 · $472,330 awarded in 2001
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
  UC4DK106993 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · fiscal years 2015
  Named on NCT01773707, NCT01030861, NCT00419562
• Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)USF: TrialNet UC4-3
  UC4DK117009 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · fiscal years 2017 to 2019
  Named on NCT01773707, NCT00419562